Literature DB >> 23435988

Thyroid hormone and cardiovascular system: from basic concepts to clinical application.

Giorgio Iervasi1, Giuseppina Nicolini.   

Abstract

Experimental and clinical findings strongly support the concept that thyroid hormone (TH) plays a fundamental role in the cardiovascular (CV) homeostasis. CV diseases represent a major public health care and economic problem being one of the principal causes of morbidity, mortality and hospitalization. In particular, chronic heart failure (HF) is one of the most common reasons for general practitioners consultations in people >65-70 years old. TH derangement may have a key role in the evolution process of HF. In HF, the main and earlier alteration of the thyroid function is referred to as "low-T3" syndrome characterized by the reduction in serum total T3 and free T3 with normal levels of thyroxine (T4) and thyrotropin (TSH). This syndrome may affect till one-third of advanced HF patients. The main goal of this mini-review is to examine the main pathophysiological and clinical links between an altered thyroid metabolism and CV diseases, namely HF during progression of disease from organ specific to systemic disorder.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23435988     DOI: 10.1007/s11739-013-0911-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  10 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 2.  Thyroid replacement therapy and heart failure.

Authors:  Anthony Martin Gerdes; Giorgio Iervasi
Journal:  Circulation       Date:  2010-07-27       Impact factor: 29.690

Review 3.  The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence.

Authors:  E Galli; A Pingitore; G Iervasi
Journal:  Heart Fail Rev       Date:  2008-12-27       Impact factor: 4.214

4.  Subclinical hypothyroidism and the risk of coronary heart disease and mortality.

Authors:  Nicolas Rodondi; Wendy P J den Elzen; Douglas C Bauer; Anne R Cappola; Salman Razvi; John P Walsh; Bjørn O Asvold; Giorgio Iervasi; Misa Imaizumi; Tinh-Hai Collet; Alexandra Bremner; Patrick Maisonneuve; José A Sgarbi; Kay-Tee Khaw; Mark P J Vanderpump; Anne B Newman; Jacques Cornuz; Jayne A Franklyn; Rudi G J Westendorp; Eric Vittinghoff; Jacobijn Gussekloo
Journal:  JAMA       Date:  2010-09-22       Impact factor: 56.272

5.  Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase.

Authors:  H Mizuma; M Murakami; M Mori
Journal:  Circ Res       Date:  2001-02-16       Impact factor: 17.367

6.  Triiodothyronine levels for risk stratification of patients with chronic heart failure.

Authors:  Alessandro Pingitore; Patrizia Landi; Maria Chiara Taddei; Andrea Ripoli; Antonio L'Abbate; Giorgio Iervasi
Journal:  Am J Med       Date:  2005-02       Impact factor: 4.965

7.  Effects of tetraiodothyronine and triiodothyronine on hamster cheek pouch microcirculation.

Authors:  A Colantuoni; P L Marchiafava; D Lapi; F S Forini; G Iervasi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-12-02       Impact factor: 4.733

8.  Association between increased mortality and mild thyroid dysfunction in cardiac patients.

Authors:  Giorgio Iervasi; Sabrina Molinaro; Patrizia Landi; Maria Chiara Taddei; Elena Galli; Fabio Mariani; Antonio L'Abbate; Alessandro Pingitore
Journal:  Arch Intern Med       Date:  2007-07-23

Review 9.  Subclinical hyperthyroidism and the risk of coronary heart disease and mortality.

Authors:  Tinh-Hai Collet; Jacobijn Gussekloo; Douglas C Bauer; Wendy P J den Elzen; Anne R Cappola; Philippe Balmer; Giorgio Iervasi; Bjørn O Åsvold; José A Sgarbi; Henry Völzke; Bariş Gencer; Rui M B Maciel; Sabrina Molinaro; Alexandra Bremner; Robert N Luben; Patrick Maisonneuve; Jacques Cornuz; Anne B Newman; Kay-Tee Khaw; Rudi G J Westendorp; Jayne A Franklyn; Eric Vittinghoff; John P Walsh; Nicolas Rodondi
Journal:  Arch Intern Med       Date:  2012-05-28

10.  Thyroid hormone and cardiac disease: from basic concepts to clinical application.

Authors:  Iordanis Mourouzis; Francesca Forini; Constantinos Pantos; Giorgio Iervasi
Journal:  J Thyroid Res       Date:  2011-06-19
  10 in total
  14 in total

Review 1.  Role of thyroid hormones in ventricular remodeling.

Authors:  Viswanathan Rajagopalan; A Martin Gerdes
Journal:  Curr Heart Fail Rep       Date:  2015-04

2.  In vivo dissolution of levothyroxine soft gel capsules.

Authors:  Giulia Fiorini; Danilo Ribichini; Renato Pasquali; Dino Vaira
Journal:  Intern Emerg Med       Date:  2016-08-25       Impact factor: 3.397

3.  MuRF1 mono-ubiquitinates TRα to inhibit T3-induced cardiac hypertrophy in vivo.

Authors:  Kristine M Wadosky; Jessica M Berthiaume; Wei Tang; Makhosi Zungu; Michael A Portman; A Martin Gerdes; Monte S Willis
Journal:  J Mol Endocrinol       Date:  2016-02-09       Impact factor: 5.098

4.  Thyroid hormone disorders: a predictor of mortality in patients with septic shock defined by Sepsis-3?

Authors:  Yan-Cun Liu; Tian-Yu Jiang; Zhen-Sen Chen; An-Long Qi; Yu-Lei Gao; Shi-Xin Li; Mu-Ming Yu; Yan-Fen Chai; Song-Tao Shou
Journal:  Intern Emerg Med       Date:  2020-11-05       Impact factor: 3.397

5.  Functional thyrotropin receptor expression in the ventricle and the effects on ventricular BNP secretion.

Authors:  Wen Huang; Jin Xu; Fei Jing; Wen-Bin Chen; Ling Gao; Hai-Tao Yuan; Jia-Jun Zhao
Journal:  Endocrine       Date:  2013-09-26       Impact factor: 3.633

6.  The Utilization of Chinese Herbal Products for Hyperthyroidism in National Health Insurance System (NHIRD) of Taiwan: A Population-Based Study.

Authors:  Cheng-Chieh Chang; Szu-Ying Wu; Yun-Ru Lai; Yu-Chiang Hung; Chung Y Hsu; Hsuan-Ju Chen; Cheng-Chung Chu; Jai-Hong Cheng; Wen-Long Hu; Chun-En Aurea Kuo
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-19       Impact factor: 2.650

7.  Hypothyroidism and its rapid correction alter cardiac remodeling.

Authors:  Georges Hajje; Youakim Saliba; Tarek Itani; Majed Moubarak; Georges Aftimos; Nassim Farès
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

8.  Myocardium of patients with dilated cardiomyopathy presents altered expression of genes involved in thyroid hormone biosynthesis.

Authors:  Carolina Gil-Cayuela; Ana Ortega; Estefanía Tarazón; Luis Martínez-Dolz; Juan Cinca; José Ramón González-Juanatey; Francisca Lago; Esther Roselló-Lletí; Miguel Rivera; Manuel Portolés
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

9.  Plasma endothelin-1 levels are increased in atrial fibrillation patients with hyperthyroidism.

Authors:  Fadia Mayyas; Nesreen Saadeh; Kusai Al-Muqbel; David R Van Wagoner
Journal:  PLoS One       Date:  2018-12-04       Impact factor: 3.240

10.  Levothyroxine improves Paraoxonase (PON-1) serum levels in patients with primary hypothyroidism: Case-control study.

Authors:  Marwa S Al-Naimi; Nawar R Hussien; Huda A Rasheed; Hayder M Al-Kuraishy; Ali I Al-Gareeb
Journal:  J Adv Pharm Technol Res       Date:  2018 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.